Reaction

Jaw Fracture reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,139 reports · 61 co-occurring drugs

As of the last recalculation, Jaw Fracture appears in 2,139 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is CHLORHEXIDINE GLUCONATE (PRR 30.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Chlorhexidine Gluconate	28	30.2	30.3
Alendronate Sodium	266	29.2	29.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	23	25.1	25.2
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	40	21.9	21.9
Ketoconazole Foam	28	18.7	18.7
Ketoconazole Cream, 2%	28	18.6	18.6
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	19	18.5	18.6
Tobramycin Solution	21	17.2	17.2
Ketoconazole	30	17.1	17.1
Tobramycin Sulfate	21	16.7	16.7
Zoledronic Acid	66	16.5	16.5
Nicotine Polacrilex Mini	25	16.4	16.4
Nicotine Polarilex	25	16.4	16.4
Emtricitabine And Tenofovir Disoproxil Fumarate	71	15.6	15.7
Risedronate Sodium	48	15.3	15.4
Emtricitabine And Tenofovir Alafenamide	17	14.7	14.7
Amitriptyline Hydrochloride	19	10.6	10.6
Tenofovir Disoproxil Fumarate	34	10.2	10.2
Clindamycin	28	9.7	9.7
Clindamycin Phosphate	31	9.1	9.2
Tobramycin	22	9.0	9.0
Goserelin	12	8.7	8.7
Alendronate Sodium Tablet	16	8.5	8.5
Exemestane	18	8.2	8.2
Dolutegravir Sodium	7	7.6	7.6
Epoetin Alfa	9	7.4	7.4
Denosumab	145	7.4	7.4
Dronabinol	6	7.3	7.3
Lubiprostone	7	7.2	7.2
Bicalutamide	11	7.1	7.1
Extended Phenytoin Sodium	12	7.0	7.0
Thalidomide	26	7.0	7.0
Alpelisib	6	6.7	6.7
Primidone	7	6.7	6.7
Raloxifene Hydrochloride	10	6.7	6.7
Nicotine Polacrilex	26	6.7	6.7
Terazosin Hydrochloride	6	6.6	6.6
Fulvestrant	22	6.5	6.5
Buprenorphine Hydrochloride, Naloxone Hydrochloride	16	6.5	6.5
Quinapril Hydrochloride	5	6.2	6.2
Nicotine	25	6.1	6.1
Conjugated Estrogens	30	5.1	5.1
Abiraterone	7	5.0	5.0
Atomoxetine Hydrochloride	12	4.9	4.9
Abatacept	57	4.1	4.1
Darbepoetin Alfa	21	3.8	3.8
Naltrexone	12	3.8	3.8
Ivacaftor	3	3.7	3.7
Diroximel Fumarate	4	3.3	3.3
Brivaracetam	3	3.2	3.3
Teriparatide	35	3.1	3.1
Ixazomib	9	3.1	3.1
Cannabidiol	7	2.9	2.9
Romosozumab-Aqqg	4	2.9	2.9
Oxymorphone Hydrochloride	3	2.5	2.5
Abiraterone Acetate	10	2.4	2.4
Dornase Alfa	4	2.0	2.0
Ixekizumab	7	1.8	1.8
Hydrocodone Bitartrate	8	1.8	1.8
Guselkumab	6	1.6	1.6
Droxidopa	3	1.4	1.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.